Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Shreders
Prolonged Benefit From Ipilimumab Correlates With Improved Outcomes From Subsequent Pembrolizumab
Cancer immunology research
Cancer Research
Immunology
Related publications
Correction To: Prolonged Stable Disease in a Uveal Melanoma Patient With Germline MBD4 Nonsense Mutation Treated With Pembrolizumab and Ipilimumab
Immunogenetics
Immunology
Genetics
Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab
Journal of Cutaneous Immunology and Allergy
Serum Cytokine Levels as Predictive Biomarkers of Benefit From Ipilimumab in Small Cell Lung Cancer
OncoImmunology
Oncology
Allergy
Immunology
P1.16-01 Prognostic Variables Associated With Improved Outcomes in Stage III NSCLC Patients Treated With Consolidation Pembrolizumab
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Extended Dose Ipilimumab With a Peptide Vaccine: Immune Correlates Associated With Clinical Benefit in Patients With Resected High-Risk Stage IIIc/IV Melanoma
Clinical Cancer Research
Cancer Research
Oncology
498. Prolonged Benefit From Systemic rAAV8 in a Canine Model of Myotubular Myopathy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Respiratory Disparity? Obese People May Not Benefit From Improved Air Quality
Environmental Health Perspectives
Mutagenesis
Public Health
Environmental
Health
Toxicology
Occupational Health
Outcomes by Line of Therapy and Programmed Death Ligand 1 Expression in Patients With Advanced Melanoma Treated With Pembrolizumab or Ipilimumab in KEYNOTE-006: A Randomised Clinical Trial
European Journal of Cancer
Cancer Research
Oncology
Prolonged Expression of the Γ-H2ax DNA Repair Biomarker Correlates With Excess Acute and Chronic Toxicity From Radiotherapy Treatment
International Journal of Cancer
Cancer Research
Oncology
